There is no single test available which can help in the diagnosis of PCOD. The doctor begins the treatment by asking questions about the symptoms such as weight changes or skipped periods. The doctor may question you about the medical history of your family. A physical examination would be done as well as the weight will be monitored by your doctor. Diagnosis and management of polycystic ovarian diseases also involve ordering lab tests such level of androgen and blood sugar. Ovaries may also be evaluated with the aid of a sonogram.
PCOD clinical features play a vital role in assisting the development of a treatment plan. Generally, a family history of individuals with PCOD may demonstrate diabetes, metabolic syndrome, obesity, infertility, hirsutism, adrenal enzyme deficiencies and menstrual disorders.
As per PCOD clinical presentations, individuals with abnormal patterns of menstruation cycle have a history that can be traced back to menarche. Some women experience less than nine menstrual periods in a year. Many experience absence of periods for six months. Infertility and dysfunctional uterine bleeding are also considered to be the consequences of such menstrual cycles.
Hyperandrogenism has as well been noted while studying clinical presentation of PCOS. This condition manifests as excess in facial and body hair. The distribution pattern is more or less similar to male pattern. Hair is commonly noted on the upper lip, Linea Alba of the lower abdomen, around nipples and on the chin. Some women experience male-pattern hair loss as well as develop a lot of acne. Other signs include deepening of voice and increase in muscle mass. However, these are the symptoms noted in extreme cases.
Infertility is noted in women suffering from PCOD but not in all. Most women ovulate in an intermittent manner. Conception in such women may take longer when compared to other women. They may as well have fewer children than planned. The rate of miscarriage is high in such women.
Half of the women suffering from PCOD are obese. Several patients with PCOD demonstrate characteristics of metabolic syndrome. The condition is characterized by an increase in the waist circumference which is referred to as abdominal obesity. Elevated blood pressure is also noted in such women. Women who are suffering from the condition are at increased risk of thickening in carotid intima media and coronary artery calcification. This can contribute to atherosclerosis.
Screening for type II diabetes is suggested to women with PCOD. 10 percent of women with the condition have type II diabetes. About 30 to 40 percent of women developed impaired glucose tolerance by the time they have attained 40 years of age. Women with PCOD demonstrated symptoms of obstructive sleep apnea. This is an independent risk factor associated with cardiovascular disease.